Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Dorry Segev and Caoilfhionn Connolly.
Dorry Segev
Connection Strength
0.894
Caoilfhionn Connolly
  1. Disease Flare and Reactogenicity in Patients With Rheumatic and Musculoskeletal Diseases Following Two-Dose SARS-CoV-2 Messenger RNA Vaccination. Arthritis Rheumatol. 2022 01; 74(1):28-32.
    View in: PubMed
    Score: 0.246
  2. Absence of Humoral Response After Two-Dose SARS-CoV-2 Messenger RNA Vaccination in Patients With Rheumatic and Musculoskeletal Diseases: A Case Series. Ann Intern Med. 2021 09; 174(9):1332-1334.
    View in: PubMed
    Score: 0.237
  3. Safety of the first dose of mRNA SARS-CoV-2 vaccines in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 Mar 19.
    View in: PubMed
    Score: 0.234
  4. Antibody response to the Janssen/Johnson & Johnson SARS-CoV-2 vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1365-1366.
    View in: PubMed
    Score: 0.060
  5. High antibody response to two-dose SARS-CoV-2 messenger RNA vaccination in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 10; 80(10):1351-1352.
    View in: PubMed
    Score: 0.059
  6. Antibody response to a single dose of SARS-CoV-2 mRNA vaccine in patients with rheumatic and musculoskeletal diseases. Ann Rheum Dis. 2021 Mar 23.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.